Skip to main content

Advertisement

Log in

Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer

  • Original Article
  • Published:
International Journal of Clinical Oncology Aims and scope Submit manuscript

Abstract

Background

To analyze the causes and patterns of unexplained carcinoembryonic antigen (CEA) elevation after curative treatment in locally advanced rectal cancer patients.

Methods

Among the 1309 locally advanced rectal cancer patients treated with curative resection and radiotherapy between January 2001 and June 2011, 325 patients who postoperatively developed abnormal CEA elevation were reviewed. The unexplained CEA elevation was defined as a CEA level higher than 5 ng/mL with no evidence of cancer recurrence at the time of elevation.

Results

Of the 325 patients, 143 (44%) had unexplained CEA elevations. The causes were categorized as delayed recurrence (n = 29, 20%), non-colorectal malignancy (n = 10, 7%), and non-malignancy-related conditions (n = 104, 73%). Shorter intervals between treatment and the first CEA elevation, and a higher peak CEA level, were observed in the delayed recurrence group compared with the non-colorectal malignancy or non-malignancy-related group (intervals of 6.8 vs. 44.9 vs. 23.2 months, respectively, p = 0.002; and peak CEA levels of 9.9 vs. 7.1 vs. 6.2 ng/mL, respectively, p = 0.034). In patients who showed delayed recurrence, the interval between the first CEA elevation and diagnosis of recurrence was a median of 13.0 months (range 3.8–60.6 months). Smoking was the most common cause for non-malignancy-related conditions. The patterns of unexplained CEA elevations were defined as sporadic (n = 78, 55%), stationary (n = 37, 26%), and increasing (n = 28, 20%). The patterns were significantly different depending on the cause (p < 0.001).

Conclusions

Analysis of the patterns of unexplained CEA elevations is a reasonable approach to predict the cause of the cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Gold P, Freedman SO (1965) Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med 121(3):439–462

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Compton CC, Fielding LP, Burgart LJ et al (2000) Prognostic factors in colorectal cancer: College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124(7):979–994

    CAS  PubMed  Google Scholar 

  3. Park S-H, Kim J-C (2016) Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules. Radiat Oncol J 6(2):96–105 34(

    Article  Google Scholar 

  4. Yoon SM, Kim DY, Kim TH et al (2007) Clinical parameters predicting pathologic tumor response after preoperative chemoradiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys 69(4):1167–1172

    Article  PubMed  Google Scholar 

  5. Kim YJ, Park SC, Kim DY et al (2012) No correlation between pretreatment serum CEA levels and tumor volume in locally advanced rectal cancer patients. Clin Chim Acta 413(3–4):511–515

    Article  CAS  PubMed  Google Scholar 

  6. Duffy MJ, van Dalen A, Haglund C et al (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43(9):1348–1360

    Article  CAS  PubMed  Google Scholar 

  7. Litvak A, Cercek A, Segal N et al (2014) False-positive elevations of carcinoembryonic antigen in patients with a history of resected colorectal cancer. J Natl Compr Cancer Netw 12(6):907–913

    Article  CAS  Google Scholar 

  8. Greene FLPD., Fleming ID, Fritz AG, Balch CM, Haller DG, Morrow M (2002) American Joint Committee on Cancer. Colon and rectum. AJCC cancer staging manual, 6th edn. Springer, New York, pp 113–123

    Book  Google Scholar 

  9. Moertel CG, Fleming TR, Macdonald JS, Haller DG, Laurie JA, Tangen C (1993) An evaluation of the carcinoembryonic antigen (cea) test for monitoring patients with resected colon cancer. JAMA 270(8):943–947

    Article  CAS  PubMed  Google Scholar 

  10. Stevens D, Mackay I, Group BPS (1973) Increased carcinoembryonic antigen in heavy cigarette smokers. The Lancet 302(7840):1238–1239

    Article  Google Scholar 

  11. Stockley RA, Shaw J, Whitfield AG, Whitehead TP, Clarke CA, Burnett D (1986) Effect of cigarette smoking, pulmonary inflammation, and lung disease on concentrations of carcinoembryonic antigen in serum and secretions. Thorax 41(1):17–24

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Go VL (1976) Carcinoembryonic antigen: clinical application. Cancer 37(1 suppl):562–566

    Article  CAS  PubMed  Google Scholar 

  13. Loewenstein MS, Zamcheck N (1978) Carcinoembryonic antigen (CEA) levels in benign gastrointestinal disease states. Cancer 42(3 Suppl):1412–1418

    Article  CAS  PubMed  Google Scholar 

  14. Kwon YJ, Lee HS, Shim JY, Lee YJ. Serum carcinoembryonic antigen is positively associated with leukocyte count in Korean adults. J Clin Lab Anal. 2017;e22291

    Article  CAS  Google Scholar 

  15. No J-I, Yang J-Y, Hyun HJ, Yeon CS, Choi H-J (2013) Factors associated with serum levels of carcinoembryonic antigen in healthy non-smokers. Korean J Fam Med 34(6):413–419

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

This work was supported by a National Cancer Center Grant (NCC-1510160 & NCC-1610440).

Author information

Authors and Affiliations

Authors

Contributions

SUL: Data curation, methodology, project administration, formal analysis, writing—original draft, and writing—review and editing. EJ: Data curation, methodology, project administration, formal analysis, writing—original draft, and writing. SUL and EJ contributed equally to this study. DYK: Responsible for overall content, conceptualization, formal analysis, funding acquisition, software, and writing—review and editing. THK: Writing, reading, supervision and approval of article. JYB: Writing, investigation, reading, and approval of article. YC: Writing, investigation, reading, and approval of article. HJC: Writing, investigation, reading, and approval of article. JHO: Writing, investigation, reading, and approval of article.

Corresponding author

Correspondence to Dae Yong Kim.

Ethics declarations

Conflict of interest

All authors state that there are no conflicts of interest

Ethical approval

The study was conducted in accordance with the ethical principles of the Declaration of Helsinki and the International Conference on Harmonization guideline E6: Good Clinical Practice.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, S.U., Jwa, E., Kim, D.Y. et al. Analysis of unexplained carcinoembryonic antigen elevation after curative treatment of locally advanced rectal cancer. Int J Clin Oncol 23, 924–929 (2018). https://doi.org/10.1007/s10147-018-1293-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10147-018-1293-4

Keywords

Navigation